Transport of Transferrin Receptor-Targeted Antibodies Through the Blood-Brain Barrier for Drug Delivery to the Brain
- 25 May 2022
- book chapter
- Published by Springer Nature
- p. 527-549
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?Advanced Drug Delivery Reviews, 2014
- In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin ReceptorMolecular Pharmacology, 2011
- Astrocytes and Pericytes Differentially Modulate Blood—Brain Barrier Characteristics during Development and Hypoxic InsultJournal of Cerebral Blood Flow & Metabolism, 2010
- Macromolecular drug transport into the brain using targeted therapyJournal of Neurochemistry, 2010
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2010
- A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's diseaseNeurobiology of Disease, 2009
- The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the Centenary of His Nobel PrizePharmacology, 2008
- The Regulation of Cellular Iron MetabolismCritical Reviews in Clinical Laboratory Sciences, 2007
- Transcytosis of 6.6-nm gold-labeled transferrin: an ultrastructural study in cultured porcine blood–brain barrier endothelial cellsBrain Research, 1997
- Development of blood-brain barrier tight junctions in the rat cortexDevelopmental Brain Research, 1996